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ABSTRACT
Objective: The aim of this study was to investigate the protective effects of aspirin (AS) and vitamin C (VC) against cardiac damage induced by chronic corn 
syrup (CS) consumption via a mechanism involving sirtuin-1 (ST-1), hypoxia-inducible factor-1α (HIF-1α), and the caspase-3 pathway in rats. 
Methods: Forty male Sprague–Dawley rats (14–16 weeks) that weighed 250–300 g were randomly distributed into 5 groups, each containing 8 
rats: control group, CS+AS group, CS+VC group, CS+AS+VC group, and CS group. AS (10 mg/kg/day) and VC (200 mg/kg/day) were orally given 
to the rats. F30 (30% fructose syrup solution) was given to the rats in drinking water for 6 weeks. The rats were sacrificed by exsanguination 
24 h after the last administration. Blood samples and tissue were collected for biochemical, histopathological, and immunohistochemical 
examinations. Non-parametric Kruskal–Wallis test and Mann–Whitney U test used for the parameters without normal distribution and ANOVA 
and post-hoc LSD tests were used for parameters with a normal distribution to compare groups. 
Results: Uric acid, creatine kinase (CKMB), and lactate dehydrogenase (LDH) levels were increased in the CS group compared with the control group 
(1.45±0.39 and p=0.011; 3225.64±598.25 and p=0.004; 3906.83±1064.22 and p=0.002, respectively) and decreased in all the treatment groups. In addition, 
increased levels of MDA and decreased activity of CAT in the CS group (0.172±0.03 and p=0.000; 0.070±0.005 and p=0.007, respectively) were reversed 
with AS and VC therapy. A decrease in ST-1 activity and increases in caspase-3 and HIF-1 activities corrected by VC and AS therapy were observed.
Conclusion: AS and VC, which display antioxidant and antiapoptotic activities, ameliorated cardiac damage induced by chronic fructose consumption 
by increasing the levels of ST-1 and decreasing the levels of HIF-1α and caspase-3. (Anatol J Cardiol 2016; 16: 648-54)
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Introduction
In the United States, corn is used as the primary starch for 
producing fructose syrup (1). Corn syrup (CS) is used as an addi-
tional sweetener in snack foods, fruit juice, meat and fish products, 
dairy products, frozen dinners, and other products because it adds 
more sweetness, does not mask the original taste, is cheaper, and 
retards satiety (2). The wide usage of CS causes several adverse 
metabolic disorders, such as fatty liver disease, obesity, hyperten-
sion, type 2 diabetes mellitus, and metabolic syndrome (3).
 Insulin resistance and increasing levels of uric acid in 
plasma, which contribute to the development of these diseases, 
have been observed during chronic consumption of CS (4). 
Similarly, both these metabolic problems are regarded as risk 
factors for coronary disorders (5, 6). Hyperuricemia increases 
free oxygen radicals and causes oxidative stress via redox-
dependent pathways in cells (7). These adverse effects reduce 
the production of nitric oxide on account of vascular endothelial 
damage. As a result, endothelial injury-induced nitric oxide defi-
ciency can cause hypertension development. (8, 9). Cardiac 
damage markers such as creatine kinase (CKMB) and lactate 
dehydrogenase (LDH) also increased in hyperuricemia-related 
cardiac injuries (10, 11).
Sirtuin-1 (ST-1) is a member of the ST protein family and plays 
a crucial role in metabolic health by deacetylating many target 
proteins such as histones in muscles, adipose tissue, heart, and 
endothelium. ST-1 improves many degenerative diseases associ-
ated with neurodegeneration, cancer, and metabolic disorders 
including glucose intolerance and insulin resistance (12). ST-1 
enhances endothelial nitric oxide synthase and performs anti-
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inflammatory functions in endothelial cells and macrophages, 
downregulating the expression of various pro-inflammatory cyto-
kines (13, 14). Activation of ST-1 regulates oxidative stress, inhibits 
some pro-inflammatory pathways, and reduces apoptosis, pro-
tecting the heart from cardiovascular diseases (15-17). Absence 
of ST-1 triggers chronic inflammation and insulin resistance (18).
Hypoxia-inducible factor-1α (HIF-1α) is a transcription fac-
tor that plays a regulatory role in hypoxia and is necessary for 
maintaining homeostasis in hypoxic conditions. Also, the levels 
of HIF-1α increase in these conditions (19-22). 
Aspirin (AS), which contains acetylsalicylic acid, is different 
from other non-steroidal anti-inflammatory agents due to an 
irreversible inhibition of cyclooxygenase that results in the inhi-
bition of inflammatory mediators. Also, AS has antioxidant prop-
erties, as has been shown in many studies (23, 24).
Vitamin C (VC) is one of the most powerful antioxidant agents 
that can easily pass through membranes and is naturally impor-
tant for body functions. It plays a role in several hydroxylation 
reactions and inhibits lipid peroxidation in human plasma and 
cell membranes (25, 26).
Although the antioxidant capacity of AS and VC has been 
well studied, there are not enough studies about the protective 
effects of these agents on hyperuricemia-related cardiac dam-
age induced by CS consumption. This study aimed to investigate 
the protective effects of AS and VC on cardiac damage induced 
by chronic CS consumption via a mechanism involving ST-1, HIF-
1α, and caspase-3 immunoreactivity.
Methods
Study design
All experiments in this study were performed in accordance 
with the guidelines for animal research from the National 
Institutes of Health and were approved by the Committee on 
Animal Research at Süleyman Demirel University, Isparta 
(23/02/2012-01).
Forty male Sprague–Dawley rats weighing 250–300 g (14–16 
weeks) were used in this study. The rats were placed in a tem-
perature (21°C–22°C) and humidity (60%±5%)-controlled room 
with a 12:12-h light:dark cycle. The rats were maintained in Euro 
type 2 cages during the 6 weeks of the study. All rats were fed with 
a standard commercial chow diet (Korkuteli Yem) composed of 
88% dry material (mostly oat crust), 23% protein, 7% cellulose, 8% 
ash that does not dissolve in 2% HCl, 1%–1.8% Ca2+, 0.9% PO43-, 
0.5%–0.8% Na, 1% NaCl, 0.3% methionine, and 1% lysine. 
Chemicals
F30 CS was obtained from Toposmanoglu (Isparta, Turkey) 
and contained approximately 24% fructose and 28% dextrose in 
73% syrup total solids. During the experiment, 30% F30 solution 
was added to drinking water for each CS-fed rat.
AS 500 mg tablets (Aspirin, Bayer, Turkey), which are a com-
mercial form of acetylsalicylic acid, were used for treatment. The 
single dose per day was 10 mg/kg orally during the experiment.
VC 1000 mg tablets (Redoxon, Bayer, Turkey), which are a 
commercial form of VC, were used for treatment. The single 
dose per day was 200 mg/kg orally during the experiment.
Study groups
The rats were randomly divided into 5 groups with 8 rats 
each. The groups were as follows: 
1- Control group (Only provided unlimited feed and water) 
2- CS+AS group (30% F30 in drinking water + 10 mg/kg/day 
AS, orally) 
3- CS+VC group (30% F30 in drinking water + 200 mg/kg/day 
VC, orally) 
4- CS+AS+VC group (30% F30 CS in drinking water + 10 mg/
kg/day AS + 200 mg/kg/day VC, orally) 
5- CS group (30% F30 in drinking water).
F30 (30% fructose syrup solution) was given to rats in drink-
ing water for 6 weeks. 
Twenty-four hours after the last administration of the drugs, 
all rats were sacrificed with intraperitoneal ketamine 10% 
(Alpha, Alfas IBV) and 2% xylazine (Alfaz’s, Alfas IBV). After 
abdominal incision, blood samples were collected and cardiac 
tissues were quickly removed. Cardiac tissues were divided 
equally into 2 longitudinal sections. One-half of the cardiac tis-
sues were placed in formaldehyde solution for routine histo-
pathological and immunohistochemical examinations. The other 
half of the cardiac tissues were homogenized and kept at -80°C 
for biochemical studies. Blood samples were extracted to deter-
mine the serum levels of CKMB, LDH, and uric acid parameters.
Biochemical analysis
One-half of the heart tissue samples were collected for bio-
chemical analyses. Tissues were homogenized in a motor-driven 
tissue homogenizer (IKA Ultra-Turrax T25 Basic, IKA Labortechnik, 
Staufen, Germany) and sonicated (UW–2070, Bandelin 
Electronic, Germany) with phosphate buffer (pH 7.4). Unbroken 
cells, cell debris, and nuclei were sedimented by centrifugation 
at 10000 g for 10 min. CAT activity was measured using the 
method described by Aebi (27) and expressed as kilo-units per 
gram protein. Protein levels in the homogenate and supernatant 
were determined according to the method of Bradford et al. (28). 
MDA levels in the tissues were determined from the homoge-
nate by following the double-heating method of Draper and 
Hadley (29). An autoanalyzer (Beckman Coulter AU680, California, 
USA) was used to determine the activities of CKMB and LDH 
and uric acid levels in the supernatants of the blood samples.
Histopathological analysis
The other half of the heart samples were collected and fixed 
in 10% buffered formalin. After a routine procedure, the tissues 
were blocked in paraffin and cut to 5-μm thickness. The tissue 
sections were stained with hematoxylin–eosin (H&E) and exam-
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ined microscopically. The stained sections were evaluated by 
an experienced pathologist, who was uninformed about the 
groups, from Mehmet Akif Ersoy University. The severity of heart 
lesions was evaluated by scoring edema, hemorrhages, and 
leukocyte infiltration. Histopathological lesions were graded on 
a scale of 0 to 3, as shown in Table 1 (30). 
Immunohistochemical analysis
The heart samples were immunostained with caspase-3 
antiserum [anti-caspase-3 antibody (ab4051), 1/100 diluted; 
Abcam, Cambridge, UK], ST-1 [anti-SIRT1 antibody (E104) 
(ab32441), 1/100 diluted; Abcam, Cambridge, UK], and HIF-1α 
[anti-HIF-1alpha (H1alpha67) antibody-ChIP Grade ab1, 1/100 
diluted; Abcam, Cambridge, UK] according to the manufacturer’s 
instruction. All the slides were evaluated for immunopositivity 
and a semiquantitative analysis was carried out as detailed 
below. The overall number of positive cells in 1 high-power field 
was noted. An attempt was made to quantify the percentage of 
cells positive for each marker. For the determination of positive 
cell numbers, at least 5 low-power fields (40×) were selected 
and the total number of cells was calculated. Data from each 
animal were analyzed statistically.
Statistical analysis
Variables were presented as frequencies, percentages, 
mean±standard deviations, medians with interquartile range, or 
min–max. The Shapiro–Wilk test was used to test for a normal 
distribution of continuous variables and for the homogeneity of 
variance. Data characterized by a normal distribution were 
expressed as the mean±standard deviation. Parameters without 
such a distribution were expressed as the median with the inter-
quartile range. Groups were compared using the non-paramet-
ric Kruskal–Wallis test and Mann–Whitney U-test. Biochemical 
parameters showed a normal distribution. ANOVA and post-hoc 
LSD tests were used to compare the groups. Data were ana-
lyzed with the computer software SPSS 15.0 for Windows (SPSS 
Inc., Chicago, IL, USA). Differences were considered as signifi-
cant for p<0.05. All results were expressed as mean±SD.
Results
Biochemical analysis
The power analysis of biochemical markers was found to be 
over 0.90.
Levels of the cardiac enzymes CKMB and LDH were 
increased in the CS group compared with the control group 
(p=0.004 and p=0.002, respectively) and decreased in all the 
treatment groups.
Uric acid levels were also increased in the CS group 
(p=0.011) and decreased in all the treatment groups, but this was 
found to be significant only in the CS+AS and CS+AS+VC groups 
(p=0.001 and p=0.002, respectively) (Table 2).
As a marker of oxidative stress, MDA levels were increased 
in the CS group (p<0.001) and decreased in the CS+VC and 
CS+AS+VC groups (p=0.030 and p=0.004, respectively) but the 
reduction in this level was not significant in the CS+AS group. 
CAT activities were decreased in the CS group compared with 
the control group (p=0.007) and increased in the AS, VC, and 
AS+VC-treated groups compared with the CS group [p=0.001, 
p<0.001, and p=0.549, respectively], but this was significant 
only in the treatment groups in which these agents were used 
alone (Table 3).
Histopathological analysis
The power analysis of histopathological markers was found to 
be over 0.90 for the effects of AS and VC on CS-induced patho-
logical findings in the hearts of the examined rats. Histopathological 
examination of the hearts in the groups treated with CS revealed 
a slight hemorrhage and a small amount of neutrophil leukocyte 
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Score Grade 
0 No structural damage No lesion
1 Minimal damage Hyperemia in vessels,  
  slight margination of  
  neutrophils
2 Moderate damage Infiltrations at myocardium
3 Severe damage Degeneration of   
  myocardial cells
Table 1. Histopathological scoring criteria (30)
Groups                                         CKMB (U/L)                              LDH (U/L)                                              Uric acid (mg/dL))
 Mean±SD P  Mean±SD P Mean±SD P 
Control 1910.71±353.32  2155.65±363.87  0.97±0.09 
CS+AS 1677.69±542.69b <0.001 1947.68±556.96b 0.001 0.89±0.15b 0.001
CS+VC 1194.85±416.50b <0.001 1485.44±600.54b <0.001 1.14±0.29 
CS+AS+VC 1204.93±396.11b <0.001 1359.23±481.99b <0.001 1.02±0.27b 0.002
CS 3225.64±598.25a 0.004 3906.83±1064.22a 0.002 1.45±0.39a 0.011
AS - Aspirin; CKMB - creatine kinase; CS - corn syrup; LDH - lactate dehydrogenase; VC - vitamin C. Values are presented as means±SD. The relationships between groups and 
results of biochemical markers are assessed by one-way ANOVA. aP<0.05 compared with Control, bP<0.05 compared with CS.
Table 2. Biochemical markers of blood samples
650
margination in the venules of the myocardium, but AS and VC 
prevented or reduced heart lesions that were induced by CS (Fig. 
1). Immunohistochemical examinations of the hearts revealed 
slight increases in caspase-3 and HIF-1α activities along with a 
decrease in ST-1 activity in myocardial cells after CS administra-
tion (Fig. 2–4). Both VC and AS had an ameliorative effect on 
CS-induced heart lesions in the rats. The group with the most 
effective treatment was the CS+AS+VC group. The results of the 
statistical analysis are shown in Table 4.
Discussion
The aim of this study was to investigate the protective 
effects of AS and VC against cardiac damage induced by exces-
sive fructose intake during chronic CS consumption via activa-
tion of ST-1 and inhibition of HIF-1α. Long-term consumption of 
fructose causes several metabolic problems such as insulin 
resistance and hyperuricemia, which lead to an increase in 
reactive oxygen radicals and oxidative stress (31). Moreover, 
cardiac damage occurs under these conditions (32). As shown 
in this study, the elevated levels of uric acid and the specific 
cardiac biochemical markers CKMB and LDH reflected cardiac 
cell damage and cardiotoxicity in the CS group, and the positive 
responses of both drugs against this cardiac damage were sig-
nificant. Moreover, according to the biochemical findings, con-
comitant usage of both drugs had better results than using them 
separately. Sakr (33) determined that levels of the cardiac mark-
ers CKMB and LDH increased in a group of rats given high-
fructose diets. In a study of myocardial ischemia reperfusion 
injury in rats, elevated levels of coronary LDH and CKMB and 
high oxidative stress were noted in the high-fructose group 
compared with the control group (34). Geetha et al. (35) studied 
cardiac damage induced by a high-fructose diet in rats and 
found beneficial effects of troxerutin against cardiac damage 
induced by high-fructose CS. Sanchez et al. (36) and Khosla et 
al. (37) demonstrated the cardiovascular toxicity of hyperurice-
mia that induced oxidative stress. In this study, uric acid levels 
were increased in the hearts of the CS group and administration 
of AS and VC decreased these levels. There are not enough 
studies in the literature about the underlying mechanism of 
hyperuricemia-induced cardiac pathologies that are related to 
high fructose intake. An increase in MDA levels proved the oxi-
dative damage in the CS group. These levels decreased in 
VC-treated groups, indicating that VC exerted a more powerful 
antioxidant effect on lipid peroxidation. Also, activities of the 
antioxidant enzyme CAT decreased in the CS group and 
increased in the AS- or VC-treated groups significantly. Cavarape 
et al. (38) found decreases in the expression levels of CAT mRNA 
in high fructose-fed rats, supporting the findings of the present 
study. In another study, researchers found that CAT levels 
decreased in high fructose-fed rats (39).
According to the histopathological and immunohistochemi-
cal findings of this study, fructose feeding disrupted the struc-
ture of the heart. There was slight neutrophil margination in the 
venous vessels of the myocardium and treatment with AS, VC or 
AS+VC had a significant inhibitory effect on this pathology due 
to the antioxidant properties of these agents. There have been 
several studies about these agents and their antioxidant activity. 
For example, researchers have found that pre- and posttreat-
ment with ascorbic acid protected the myocardium from the 
toxic effect of doxorubicin by increasing CAT activities and 
decreasing MDA levels. Although disruption of myofibrils, vacu-
olization of the cytoplasm, necrosis, and inflammatory cells 
were observed in the doxorubicin-administered group, there 
was a reduced loss of myofibrils, vacuolization of the cytoplasm, 
and inflammatory cells in groups that were pre- or post-treated 
with ascorbic acid (40).
ST-1 plays an important role in regulating the degeneration, 
growth, and survival of cells. It enhances inflammation and the 
activity of antioxidant enzymes by inhibiting free radical-mediat-
ed oxidative stress via decreasing the activation of nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase (41). Besides, 
ST-1 protects the physiology of muscles against hypertrophy and 
increases mitochondrial biogenesis and fatty acid oxidation 
according to nutrient availability by deacetylating and activating 
the nuclear receptor peroxisome proliferator-activated recep-
tor-alpha (PPARa) and peroxisome proliferator-activated recep-
tor-gamma coactivator 1-alpha (42, 43). On the other hand, pro-
moting the entry of ST-1 into the nucleus induces the expression 
Groups                     MDA, µmol/mg                   CAT, kU/mg
                     protein                    protein
 Mean±SD P  Mean±SD P
Control 0.079±0.03  0.085±0.005 
CS+AS 0.129±0.04a 0.003 0.089±0.009b 0.001
CS+VC 0.101±0.01b 0.030 0.092±0.004b <0.001
CS+AS+VC 0.102±0.03b 0.004 0.074±0.000 0.549
CS 0.172±0.03a <0.001 0.070±0.005a 0.007
AS - Aspirin; CAT - catalase; CS - corn syrup; MDA - malondialdehyde; VC - vitamin C. 
Values are presented as means±SD. The relationships between groups and results of 
biochemical markers are assessed by one-way ANOVA. aP<0.05 compared with 
Control, bP<0.05 compared with CS.
Table 3. Oxidative stress markers of cardiac tissues
 Histopathological  Sirtuin-1  HIF-1α (+) Caspase-3 
 scores (+) cells (%)  cells (%) (+) cells (%)
Control 0.00±0.00a 7.40±5.39a 0.10±0.31a 0.40±0.69a
CS+AS 0.40±0.51b 3.60±1.89b 0.40±0.69b 0.50±0.84b
CS+VC 0.30±0.48b 4.60±2.17b 0.40±0.69b 0.40±0.69b
CS+AS+VC 0.10±0.31b 7.80±2.93b 0.40±0.51b 0.20±0.42b
CS 0.80±0.42a 1.80±1.39a 2.80±2.14a 1.80±2.04a
AS - Aspirin; CS - corn syrup; HIF-1α - hypoxia-inducible factor-1α; VC - vitamin C. 
Values are presented as means±SD. Differences between the means of groups 
carrying different superscripts in the same column are statistically significant (P<0.05) 
by one-way ANOVA. aP<0.05 compared with Control, bP<0.05 compared with CS.
Table 4. Results of statistical analysis of histopathological and 
immunohistochemical findings
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of endothelial nitric oxide synthase (eNOS), which plays a role in 
responding to calorie restriction, increasing myocardial isch-
emic tolerance in the heart (44). In this study, ST-1 staining levels 
significantly decreased in the CS group compared with the 
control group. This could be explained in 2 ways. Firstly, the 
oxidative stress capacity in cardiac damage in the CS group was 
more than the antioxidant activity of cells. Secondly, the positive 
effect on the cells and inhibitory effect on oxidative stress of 
ST-1 may be suppressed due to decreases in ST-1 levels with 
high-dose fructose syrup. ST-1 levels increased significantly in 
groups that were given AS, VC, and both AS and VC. This situa-
tion can be explained as follows: either treatment with AS or VC 
Figure 4. a-e. HIF-1α immunoreactions of the heart: (a) HIF-1α-negative immunoreaction of Control group heart; (b) no HIF-1α reaction of heart in 
CS+AS group; (c) negative HIF-1α expression in heart from CS+VC group; (d) negative reaction in heart from CS+AS+VC group; (e) slight increase in 
positive immunoreaction in myocardial cells of heart in CS group (arrows). Streptavidin-biotin-peroxidase method, Bar=50 µm.
Figure 1. a-e. Histopathology of the heart: (a) normal histology of Control group heart; (b) normal appearance of heart in CS+AS group; (c) normal 
histological appearance of heart from CS+VC group; (d) no pathological finding in heart from CS+AS+VC group; (e) slight neutrophil margination 
(arrows) in the venous vessels of the myocardium in heart of CS+AS group. HE, Bar=50 µm.
Figure 2. a-e. Caspase immunoreaction of the heart: (a) caspase-3-negative immunoreaction of Control group heart; (b) no caspase-3 expression of 
heart in CS+AS group; (c) negative caspase-3 immunoreaction of heart from CS+VC group; (d) negative reaction in heart from CS+AS+VC group; (e) 
slight caspase-3-positive immunoreaction in myocardial cells of heart in CS group (arrows). Streptavidin-biotin-peroxidase method, Bar=50 µm.
Figure 3. a-e. ST-1 immunoreactions of the heart: (a) marked positive immunoreaction of Control group heart; (b) ST-positive immunoreaction of heart 
in CS+AS group; (c) positive ST expression in heart from CS+VC group; (d) positive reaction in heart from CS+AS+VC group; (e) decreased ST 
immunoreaction in myocardial cells of heart in CS group (arrows). Streptavidin-biotin-peroxidase method, Bar=50 µm.
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increased the levels of ST-1 expression directly or both these 
drugs protected ST-1 cells against oxidative stress induced by 
CS. In a study, the authors reported that AS enhanced the acti-
vation of ST-1 and AMP-activated protein kinase signaling path-
ways in endothelial cell toxicity caused by vinorelbine due to its 
anti-inflammatory activity (45). Also, in another study VC stimu-
lated the activity of ST-1, which deacetylated 7-amino-4-methyl-
coumarin-labeled acetylated peptide, supporting our study (46). 
Staining levels of the indicator of hypoxia HIF-1α increased in 
the CS group and decreased in all the treatment groups, as in 
caspase-3 staining, in our study. In an ischemic myocardium 
study, immunohistochemical expression of HIF-1α occurred in 
the marginal area of ischemia, similar to caspase-3 expression 
(47). On the other hand, there was another relationship or inter-
action between ST-1 and HIF-1α. When a redox change was 
restricted by blocking glycolysis, ST-1 was upregulated, which 
led to the deacetylation and inactivation of HIF-1α, even 
in hypoxia (48). In addition, ST-1 restricted the formation of neo-
intima in wire-injured femoral arteries by inhibiting HIF-1α 
expression in hypoxic conditions (49). Similarly, the findings of 
our study supported this study, as the decrease in HIF-1α levels 
was parallel to the increase in ST-1 levels.
Study limitations 
The exogenous administration of CS, in particular, as a cause 
of insulin resistance does not necessarily mimic the physiopath-
ological conditions in diabetes mellitus type II. This may affect the 
development of hyperglycemic conditions and, after that, the 
occurrence of insulin resistance. This chronic condition causes 
much tissue damage. It is recognized as an accurate model for 
insulin resistance that is related to cardiovascular diseases.
Despite these potential limitations, we feel that this approach 
is useful for assessing the pharmacological roles of AS and VC 
with the aim of determining the protective effects of AS and VC, 
via regulating ST-1 and HIF-1α, against cardiovascular diseases 
during their therapeutic use.
Our protocol was specifically designed to define and char-
acterize the cardiovascular effects of CS rather than to address 
pathophysiological mechanisms. Once the effects of ST-1 and 
HIF-1α are clearly demonstrated, hypotheses should be gener-
ated to stimulate the additional research that is needed to clarify 
the inflammatory mechanism involved.
Conclusion
In accordance with our findings, ST-1 and HIF-1α can be 
useful for investigation of the oxidative-state apoptotic proper-
ties of cardiovascular drugs on cardiac toxicity. ST-1 and HIF-1α 
should be investigated, especially targeting the inflammatory 
processes in the intracellular mechanisms by second messen-
ger regulation in cardiovascular diseases. 
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